Genomewide interaction and enrichment analysis on antidepressant response

N. Antypa, A. Drago, A. Serretti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Genomewide association studies (GWASs) on antidepressant efficacy have yielded modest results. A possible reason is that response is influenced by other factors, which possibly interact with genetic variation. We used a GWAS model to predict antidepressant response, by including predictors previously known to affect response, such as quality of life (QoL). We also evaluated the association between genes, previously implicated in gene-environment (G × E) interactions, and response using an enrichment analysis. Method We examined a sample of 1426 depressed patients from the Sequenced Treatment Alternatives to Relieve Depression (STAR-D) trial: 774 responders, 652 non-responders and 418 865 single nucleotide polymorphisms (SNPs) were analysed. First, in a GWAS model, we investigated whether genetic variations interact with patients' levels of QoL to predict response, after controlling for demographic characteristics, severity and population stratification. Second, we conducted an enrichment analysis exploring whether candidate genes that have emerged from prior G × E interaction studies on depression are associated with treatment response. Results The GWAS model, with QoL as a moderator, yielded one SNP (rs520210) associated with response in the NEDD4L gene (p = 3.64 × 10-8). In the Caucasian sample only, we observed a drop in significance for this SNP. The enrichment analysis showed that SNPs within serotonergic genes contained more significant markers that predicted response, compared with a random set of genes in the genome. Conclusions Our findings point to possible target genes, which are proposed for further independent replication. Our enrichment analysis provides further support, in a genomewide context, of the role of serotonergic genes in influencing antidepressant response.

Original languageEnglish
Pages (from-to)753-765
Number of pages13
JournalPsychological Medicine
Volume44
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Antidepressive Agents
Single Nucleotide Polymorphism
Genes
Gene-Environment Interaction
Quality of Life
Population Characteristics
Demography
Genome
Therapeutics

Keywords

  • Antidepressant response
  • Enrichment analysis
  • Genomewide interaction
  • Quality of life

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Applied Psychology

Cite this

Genomewide interaction and enrichment analysis on antidepressant response. / Antypa, N.; Drago, A.; Serretti, A.

In: Psychological Medicine, Vol. 44, No. 4, 2014, p. 753-765.

Research output: Contribution to journalArticle

Antypa, N. ; Drago, A. ; Serretti, A. / Genomewide interaction and enrichment analysis on antidepressant response. In: Psychological Medicine. 2014 ; Vol. 44, No. 4. pp. 753-765.
@article{bf79c6a164e34e5587906d5bbb980b22,
title = "Genomewide interaction and enrichment analysis on antidepressant response",
abstract = "Background Genomewide association studies (GWASs) on antidepressant efficacy have yielded modest results. A possible reason is that response is influenced by other factors, which possibly interact with genetic variation. We used a GWAS model to predict antidepressant response, by including predictors previously known to affect response, such as quality of life (QoL). We also evaluated the association between genes, previously implicated in gene-environment (G × E) interactions, and response using an enrichment analysis. Method We examined a sample of 1426 depressed patients from the Sequenced Treatment Alternatives to Relieve Depression (STAR-D) trial: 774 responders, 652 non-responders and 418 865 single nucleotide polymorphisms (SNPs) were analysed. First, in a GWAS model, we investigated whether genetic variations interact with patients' levels of QoL to predict response, after controlling for demographic characteristics, severity and population stratification. Second, we conducted an enrichment analysis exploring whether candidate genes that have emerged from prior G × E interaction studies on depression are associated with treatment response. Results The GWAS model, with QoL as a moderator, yielded one SNP (rs520210) associated with response in the NEDD4L gene (p = 3.64 × 10-8). In the Caucasian sample only, we observed a drop in significance for this SNP. The enrichment analysis showed that SNPs within serotonergic genes contained more significant markers that predicted response, compared with a random set of genes in the genome. Conclusions Our findings point to possible target genes, which are proposed for further independent replication. Our enrichment analysis provides further support, in a genomewide context, of the role of serotonergic genes in influencing antidepressant response.",
keywords = "Antidepressant response, Enrichment analysis, Genomewide interaction, Quality of life",
author = "N. Antypa and A. Drago and A. Serretti",
year = "2014",
doi = "10.1017/S0033291713001554",
language = "English",
volume = "44",
pages = "753--765",
journal = "Psychological Medicine",
issn = "0033-2917",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Genomewide interaction and enrichment analysis on antidepressant response

AU - Antypa, N.

AU - Drago, A.

AU - Serretti, A.

PY - 2014

Y1 - 2014

N2 - Background Genomewide association studies (GWASs) on antidepressant efficacy have yielded modest results. A possible reason is that response is influenced by other factors, which possibly interact with genetic variation. We used a GWAS model to predict antidepressant response, by including predictors previously known to affect response, such as quality of life (QoL). We also evaluated the association between genes, previously implicated in gene-environment (G × E) interactions, and response using an enrichment analysis. Method We examined a sample of 1426 depressed patients from the Sequenced Treatment Alternatives to Relieve Depression (STAR-D) trial: 774 responders, 652 non-responders and 418 865 single nucleotide polymorphisms (SNPs) were analysed. First, in a GWAS model, we investigated whether genetic variations interact with patients' levels of QoL to predict response, after controlling for demographic characteristics, severity and population stratification. Second, we conducted an enrichment analysis exploring whether candidate genes that have emerged from prior G × E interaction studies on depression are associated with treatment response. Results The GWAS model, with QoL as a moderator, yielded one SNP (rs520210) associated with response in the NEDD4L gene (p = 3.64 × 10-8). In the Caucasian sample only, we observed a drop in significance for this SNP. The enrichment analysis showed that SNPs within serotonergic genes contained more significant markers that predicted response, compared with a random set of genes in the genome. Conclusions Our findings point to possible target genes, which are proposed for further independent replication. Our enrichment analysis provides further support, in a genomewide context, of the role of serotonergic genes in influencing antidepressant response.

AB - Background Genomewide association studies (GWASs) on antidepressant efficacy have yielded modest results. A possible reason is that response is influenced by other factors, which possibly interact with genetic variation. We used a GWAS model to predict antidepressant response, by including predictors previously known to affect response, such as quality of life (QoL). We also evaluated the association between genes, previously implicated in gene-environment (G × E) interactions, and response using an enrichment analysis. Method We examined a sample of 1426 depressed patients from the Sequenced Treatment Alternatives to Relieve Depression (STAR-D) trial: 774 responders, 652 non-responders and 418 865 single nucleotide polymorphisms (SNPs) were analysed. First, in a GWAS model, we investigated whether genetic variations interact with patients' levels of QoL to predict response, after controlling for demographic characteristics, severity and population stratification. Second, we conducted an enrichment analysis exploring whether candidate genes that have emerged from prior G × E interaction studies on depression are associated with treatment response. Results The GWAS model, with QoL as a moderator, yielded one SNP (rs520210) associated with response in the NEDD4L gene (p = 3.64 × 10-8). In the Caucasian sample only, we observed a drop in significance for this SNP. The enrichment analysis showed that SNPs within serotonergic genes contained more significant markers that predicted response, compared with a random set of genes in the genome. Conclusions Our findings point to possible target genes, which are proposed for further independent replication. Our enrichment analysis provides further support, in a genomewide context, of the role of serotonergic genes in influencing antidepressant response.

KW - Antidepressant response

KW - Enrichment analysis

KW - Genomewide interaction

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84896451365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896451365&partnerID=8YFLogxK

U2 - 10.1017/S0033291713001554

DO - 10.1017/S0033291713001554

M3 - Article

VL - 44

SP - 753

EP - 765

JO - Psychological Medicine

JF - Psychological Medicine

SN - 0033-2917

IS - 4

ER -